Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract); allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - active: allergen extracts 0.1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract); allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - active: allergen extracts 0.1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 0.1 ic/ml (rumex acetosa pollen extract); allergen extracts 1 ic/ml (rumex acetosa pollen extract); allergen extracts 10 ic/ml (rumex acetosa pollen extract) - solution for injection - active: allergen extracts 0.1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 1 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water active: allergen extracts 10 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

jubilant hollisterstier llc - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

jubilant hollisterstier llc - amaranthus palmeri pollen (unii: 1gh3wv23kh) (amaranthus palmeri pollen - unii:1gh3wv23kh) - amaranthus palmeri pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

jubilant hollisterstier llc - populus deltoides pollen (unii: 476dvv63wp) (populus deltoides pollen - unii:476dvv63wp) - populus deltoides pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

jubilant hollisterstier llc - quercus rubra pollen (unii: svw19et93c) (quercus rubra pollen - unii:svw19et93c) - quercus rubra pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the